Greater Delaware Valley Society of Transplant Surgeons
401 N 3rd Street, Phila, PA · IRS data through FY2024
Revenue, expenses and net assets
Revenue Expenses Net assets
| Tax year | Revenue | Expenses | Net assets |
|---|---|---|---|
| FY2024 | $152,878,717 | $147,557,181 | $113,095,832 |
| FY2023 | $134,455,101 | $126,360,792 | $104,081,485 |
| FY2022 | $125,543,961 | $118,985,440 | $89,504,333 |
| FY2021 | $115,440,008 | $113,208,797 | $93,155,818 |
| FY2020 | $102,693,100 | $92,648,126 | $88,731,580 |
| FY2019 | $101,919,082 | $89,002,623 | $73,739,381 |
| FY2018 | $89,854,991 | $79,841,051 | $59,247,371 |
| FY2017 | $80,939,143 | $73,726,608 | $51,557,914 |
| FY2016 | $75,597,761 | $77,170,922 | $42,609,260 |
| FY2015 | $69,666,424 | $64,342,909 | $43,463,355 |
| FY2014 | $60,073,114 | $56,606,885 | $38,980,685 |
| FY2013 | $60,047,112 | $67,747,411 | $35,804,021 |
| FY2012 | $52,743,249 | $47,457,683 | $43,348,072 |
| FY2011 | $53,401,671 | $45,557,346 | $37,500,581 |
Form 990 filings
The returns filed by Greater Delaware Valley Society of Transplant Surgeons (EIN 23-7388767), including Form 990 PDFs and e-file data by year, are available in ProPublica's Nonprofit Explorer. The figures on this page come from IRS data files built from those returns.
Where the revenue came from
| Source | Amount | % of revenue |
|---|---|---|
| Contributions & grants | $0 | 0% |
| Program service revenue | $149,069,085 | 98% |
| Other revenue | $3,809,632 | 2% |
Where the money was spent
| Category | Amount | % of expenses |
|---|---|---|
| Program services | $137,304,741 | 93% |
| Management & general | $10,252,440 | 7% |
| Fundraising | $0 | 0% |
What the numbers show
- Program service revenue made up 98% of total revenue in FY2024.
- Program services accounted for 93% of functional expenses, management & general 7%, and fundraising 0%.
- 93% of functional expenses went to program services in FY2024. That is higher than 86.6% of 157 Medical Research organizations nationwide (too few in PA for a state comparison).
- Net assets covered about 9.2 months of expenses at the end of the reporting year. That puts it in the 40th percentile among 120 Medical Research organizations in PA.
- Total revenue was the highest among 122 Medical Research organizations in PA.
- Total revenue rose from $53,401,671 in FY2011 to $152,878,717 in FY2024. Revenue increased in 12 and decreased in 1 of 13 year-over-year comparisons.
- Expenses exceeded revenue in 2 of 14 reported years (FY2013, FY2016).
- Net assets grew from $37,500,581 to $113,095,832 between FY2011 and FY2024.
- Listed in the IRS Publication 78 data as eligible to receive tax-deductible contributions (public charity).
Figures compared against other organizations of the same NTEE program area in the same state. See the methodology page for how these are calculated and the guide to reading nonprofit financials for their limits.
About this organization
TO RECOVER AND ALLOCATE ORGANS AND TISSUES USED IN LIFE-SAVING AND LIFE-ENHANCING TRANSPLANTS.
IRS status
| Ruling year | 1975 |
| Subsection | 501(c)(3) |
| Classification | Public charity |
| Program area (NTEE) | H9B — Medical Research |
| Donations | Listed in the IRS Publication 78 data as eligible to receive tax-deductible contributions (public charity). |
Similar organizations
- American Association for Cancer Research — Philadelphia, PA · $129,520,731
- Institute for Cancer Research — Philadelphia, PA · $94,545,853
- The Wistar Institute of Anatomy and Biology — Philadelphia, PA · $77,322,000
- Nsabp Foundation Inc — Pittsburgh, PA · $44,121,085
Source: Internal Revenue Service — Exempt Organizations Business Master File (downloaded November 4, 2026), Statistics of Income extracts, Form 990 e-file data, Publication 78 and the Automatic Revocation list. Figures are as reported by the organization; IRS processing may adjust them. This is not a charity rating and not tax advice. Confirm deductibility in IRS Tax Exempt Organization Search.
Think something here is wrong or should be removed? Use the contact form — we act on removal requests within 30 days.